Antibody-Drug Conjugates News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–7 of 7 articles
Friday Five: ASCO Takeaways, ADA Focus, China Deals & More – Clinical Trials
Pharma Partnering US: $77.3B Licensing Deals in Q1 2026
Aclaris Therapeutics ATI-052 Shows Promising 45-Day Half-Life in Phase 1a Trial Results
Tovecimig Shows 56% Reduction in Cancer Progression Risk in Biliary Tract Cancer Trial
Oncology Data Landscape 2026: Key Trends & Upcoming Readouts
AACR 2024: Oncology News & Key Takeaways - Day 1
Salubris Biotherapeutics JK06 Shows Promise in Phase 1/2 Cancer Trial at AACR 2024